GenMark Diagnostics (GNMK) reported a fourth quarter loss of $0.15 per share after the close Tuesday, compared to the loss of $0.27 per share last year. The consensus estimate was for a loss of $0.21.
GenMark Diagnostics gapped open higher Wednesday and has continued to rise in early trade. The stock is now up 1.15 at $12.20 and has climbed to a new high for the year.
For comments and feedback: editorial@rttnews.com